Cargando…

The Impact of COVID-19 on Hematology-Oncology Fellowship Programs: Program Director Perspectives

Introduction The COVID-19 pandemic has significantly affected many aspects of healthcare, including medical education and training. Its impact on hematology/oncology (HO) fellowship programs has not yet been characterized. Methods The American Society of Hematology (ASH) and American Society of Clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Velazquez Manana, Ana I., Durani, Urshila, Reynolds, Robby, Kumbamu, Ashok, Das, Devika G., Murphy, Martina C., Henry, Elizabeth, Lee, Alfred Ian, Marshall, Ariela L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544190/
http://dx.doi.org/10.1182/blood-2020-141514
_version_ 1784589762042003456
author Velazquez Manana, Ana I.
Durani, Urshila
Reynolds, Robby
Kumbamu, Ashok
Das, Devika G.
Murphy, Martina C.
Henry, Elizabeth
Lee, Alfred Ian
Marshall, Ariela L.
author_facet Velazquez Manana, Ana I.
Durani, Urshila
Reynolds, Robby
Kumbamu, Ashok
Das, Devika G.
Murphy, Martina C.
Henry, Elizabeth
Lee, Alfred Ian
Marshall, Ariela L.
author_sort Velazquez Manana, Ana I.
collection PubMed
description Introduction The COVID-19 pandemic has significantly affected many aspects of healthcare, including medical education and training. Its impact on hematology/oncology (HO) fellowship programs has not yet been characterized. Methods The American Society of Hematology (ASH) and American Society of Clinical Oncology (ASCO) sent an anonymous survey in June 2020 to all HO program directors (PDs) addressing program changes during the COVID-19 pandemic and their perception of impact on trainees' experience, education, and mental health. The survey included 32 multiple-choice and open-ended questions. Participants who completed the survey received a $10 gift card. Quantitative descriptive analyses of multiple-choice questions were conducted. Open-ended responses were analyzed qualitatively using NVivo software. Results Of 233 invited PDs, 103 (44%) respondents completed the survey; 22 additional surveys were incomplete and not included in the analysis. Table 1 summarizes PDs and program characteristics. In response to the pandemic, 42% (N=43) of programs removed fellows from outpatient clinics and 63% (N=65) changed research location to home (Figure 1). Most PDs reported their fellows were participating in telehealth for HO care (79%, N=81) and 21% (N=22) had their fellows re-deployed to cover medicine and other non-HO services. To support fellows' mental health most programs held additional virtual meetings (76%, N=78) and social events (52%, N=54). Twenty one percent of PDs (N=22) reported their program's professional development funds were completely cut or frozen and 17% (N=17) had funds cut slightly. Most PDs reported the pandemic negatively impacted fellowship overall (67% slight to significant negative impact, N=69), 72% identified clinical education as negatively impacted (72% slight to significant negative impact, N=74), and 35% (N=36) reported significant negative impact on research training/productivity. Twenty three percent (N=24) of PDs thought their fellows were not able to make good use of their time during the pandemic, professionally speaking. One third (33%, N=34) of PDs anticipated the pandemic would lead to lack of fellow clinical preparedness, 24% (N=25) with need to make up clinical rotations, and 15% (N=15) anticipated a negative impact on HO board pass rates. Post-pandemic, most PDs plan to maintain some virtual educational sessions (73%, N=75) and telehealth in fellows' continuity clinic (55%, N=57). Among PDs, the prevalence of burnout increased from 16% (N=16) pre-pandemic to 45% (N=46) during the pandemic (p<0.0001). Seventeen percent (N=18) of PDs witnessed moderate signs of fellow burnout and 52% (N=54) witnessed minor signs of fellow burnout during the pandemic. Several educational and research constraints were identified via qualitative analysis: limited in-person clinical rotations, supervision of telehealth encounters, training year promotion and making up clinical time, limited professional development activities, board exam cancellations, and inability to perform research. Additional PD-identified trainee concerns included: ability to obtain childcare, separation from family, and Visa concerns among international fellows. PDs anticipated that financial constraints leading to cuts or removal of discretionary funds may have negative consequences for fellows' professional development activities and could force PDs to decrease program size in the future. PD recommendations for ASH and ASCO included: reducing or eliminating fellow membership fees, providing free access to educational materials and meetings, eliminating in-training examination fees, providing virtual sessions on career development, telehealth and wellness, virtual journal clubs, PD webinars focused on navigating fellowship issues and virtual interviews, and extending ASCO YIA funding for a second year. Conclusions PDs reported that their fellowship programs' clinical, educational, and research experiences have been impacted by the COVID-19 pandemic. PDs are concerned about the impact of budget cuts on fellows' professional and career development. PD burnout increased during the pandemic and most PDs observed at least mild burnout among their fellows. Professional societies can support fellowship programs by limiting fees and costs associated with membership, exams, and meetings, and increasing virtual opportunities for both fellows and PDs. [Figure: see text] DISCLOSURES: Velazquez Manana:Portola Pharmaceuticals: Other: Immediate family member stock ownership; Midatech: Other: Immediate family member stock ownership; Corbus Pharmaceuticals: Other: Immediate family member stock ownership.
format Online
Article
Text
id pubmed-8544190
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-85441902021-10-25 The Impact of COVID-19 on Hematology-Oncology Fellowship Programs: Program Director Perspectives Velazquez Manana, Ana I. Durani, Urshila Reynolds, Robby Kumbamu, Ashok Das, Devika G. Murphy, Martina C. Henry, Elizabeth Lee, Alfred Ian Marshall, Ariela L. Blood 901.Health Services Research-Non-Malignant Conditions Introduction The COVID-19 pandemic has significantly affected many aspects of healthcare, including medical education and training. Its impact on hematology/oncology (HO) fellowship programs has not yet been characterized. Methods The American Society of Hematology (ASH) and American Society of Clinical Oncology (ASCO) sent an anonymous survey in June 2020 to all HO program directors (PDs) addressing program changes during the COVID-19 pandemic and their perception of impact on trainees' experience, education, and mental health. The survey included 32 multiple-choice and open-ended questions. Participants who completed the survey received a $10 gift card. Quantitative descriptive analyses of multiple-choice questions were conducted. Open-ended responses were analyzed qualitatively using NVivo software. Results Of 233 invited PDs, 103 (44%) respondents completed the survey; 22 additional surveys were incomplete and not included in the analysis. Table 1 summarizes PDs and program characteristics. In response to the pandemic, 42% (N=43) of programs removed fellows from outpatient clinics and 63% (N=65) changed research location to home (Figure 1). Most PDs reported their fellows were participating in telehealth for HO care (79%, N=81) and 21% (N=22) had their fellows re-deployed to cover medicine and other non-HO services. To support fellows' mental health most programs held additional virtual meetings (76%, N=78) and social events (52%, N=54). Twenty one percent of PDs (N=22) reported their program's professional development funds were completely cut or frozen and 17% (N=17) had funds cut slightly. Most PDs reported the pandemic negatively impacted fellowship overall (67% slight to significant negative impact, N=69), 72% identified clinical education as negatively impacted (72% slight to significant negative impact, N=74), and 35% (N=36) reported significant negative impact on research training/productivity. Twenty three percent (N=24) of PDs thought their fellows were not able to make good use of their time during the pandemic, professionally speaking. One third (33%, N=34) of PDs anticipated the pandemic would lead to lack of fellow clinical preparedness, 24% (N=25) with need to make up clinical rotations, and 15% (N=15) anticipated a negative impact on HO board pass rates. Post-pandemic, most PDs plan to maintain some virtual educational sessions (73%, N=75) and telehealth in fellows' continuity clinic (55%, N=57). Among PDs, the prevalence of burnout increased from 16% (N=16) pre-pandemic to 45% (N=46) during the pandemic (p<0.0001). Seventeen percent (N=18) of PDs witnessed moderate signs of fellow burnout and 52% (N=54) witnessed minor signs of fellow burnout during the pandemic. Several educational and research constraints were identified via qualitative analysis: limited in-person clinical rotations, supervision of telehealth encounters, training year promotion and making up clinical time, limited professional development activities, board exam cancellations, and inability to perform research. Additional PD-identified trainee concerns included: ability to obtain childcare, separation from family, and Visa concerns among international fellows. PDs anticipated that financial constraints leading to cuts or removal of discretionary funds may have negative consequences for fellows' professional development activities and could force PDs to decrease program size in the future. PD recommendations for ASH and ASCO included: reducing or eliminating fellow membership fees, providing free access to educational materials and meetings, eliminating in-training examination fees, providing virtual sessions on career development, telehealth and wellness, virtual journal clubs, PD webinars focused on navigating fellowship issues and virtual interviews, and extending ASCO YIA funding for a second year. Conclusions PDs reported that their fellowship programs' clinical, educational, and research experiences have been impacted by the COVID-19 pandemic. PDs are concerned about the impact of budget cuts on fellows' professional and career development. PD burnout increased during the pandemic and most PDs observed at least mild burnout among their fellows. Professional societies can support fellowship programs by limiting fees and costs associated with membership, exams, and meetings, and increasing virtual opportunities for both fellows and PDs. [Figure: see text] DISCLOSURES: Velazquez Manana:Portola Pharmaceuticals: Other: Immediate family member stock ownership; Midatech: Other: Immediate family member stock ownership; Corbus Pharmaceuticals: Other: Immediate family member stock ownership. American Society of Hematology 2020-11-05 2021-08-03 /pmc/articles/PMC8544190/ http://dx.doi.org/10.1182/blood-2020-141514 Text en Copyright © 2020 American Society of Hematology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle 901.Health Services Research-Non-Malignant Conditions
Velazquez Manana, Ana I.
Durani, Urshila
Reynolds, Robby
Kumbamu, Ashok
Das, Devika G.
Murphy, Martina C.
Henry, Elizabeth
Lee, Alfred Ian
Marshall, Ariela L.
The Impact of COVID-19 on Hematology-Oncology Fellowship Programs: Program Director Perspectives
title The Impact of COVID-19 on Hematology-Oncology Fellowship Programs: Program Director Perspectives
title_full The Impact of COVID-19 on Hematology-Oncology Fellowship Programs: Program Director Perspectives
title_fullStr The Impact of COVID-19 on Hematology-Oncology Fellowship Programs: Program Director Perspectives
title_full_unstemmed The Impact of COVID-19 on Hematology-Oncology Fellowship Programs: Program Director Perspectives
title_short The Impact of COVID-19 on Hematology-Oncology Fellowship Programs: Program Director Perspectives
title_sort impact of covid-19 on hematology-oncology fellowship programs: program director perspectives
topic 901.Health Services Research-Non-Malignant Conditions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544190/
http://dx.doi.org/10.1182/blood-2020-141514
work_keys_str_mv AT velazquezmananaanai theimpactofcovid19onhematologyoncologyfellowshipprogramsprogramdirectorperspectives
AT duraniurshila theimpactofcovid19onhematologyoncologyfellowshipprogramsprogramdirectorperspectives
AT reynoldsrobby theimpactofcovid19onhematologyoncologyfellowshipprogramsprogramdirectorperspectives
AT kumbamuashok theimpactofcovid19onhematologyoncologyfellowshipprogramsprogramdirectorperspectives
AT dasdevikag theimpactofcovid19onhematologyoncologyfellowshipprogramsprogramdirectorperspectives
AT murphymartinac theimpactofcovid19onhematologyoncologyfellowshipprogramsprogramdirectorperspectives
AT henryelizabeth theimpactofcovid19onhematologyoncologyfellowshipprogramsprogramdirectorperspectives
AT leealfredian theimpactofcovid19onhematologyoncologyfellowshipprogramsprogramdirectorperspectives
AT marshallarielal theimpactofcovid19onhematologyoncologyfellowshipprogramsprogramdirectorperspectives
AT velazquezmananaanai impactofcovid19onhematologyoncologyfellowshipprogramsprogramdirectorperspectives
AT duraniurshila impactofcovid19onhematologyoncologyfellowshipprogramsprogramdirectorperspectives
AT reynoldsrobby impactofcovid19onhematologyoncologyfellowshipprogramsprogramdirectorperspectives
AT kumbamuashok impactofcovid19onhematologyoncologyfellowshipprogramsprogramdirectorperspectives
AT dasdevikag impactofcovid19onhematologyoncologyfellowshipprogramsprogramdirectorperspectives
AT murphymartinac impactofcovid19onhematologyoncologyfellowshipprogramsprogramdirectorperspectives
AT henryelizabeth impactofcovid19onhematologyoncologyfellowshipprogramsprogramdirectorperspectives
AT leealfredian impactofcovid19onhematologyoncologyfellowshipprogramsprogramdirectorperspectives
AT marshallarielal impactofcovid19onhematologyoncologyfellowshipprogramsprogramdirectorperspectives